Comparative Effectiveness Trial in the Treatment of Pediatric Plaque Morphea

NCT02680717 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Unable to obtain IRB approval at all sites

Conditions

Scleroderma

Interventions

DRUG: Clobetasol
DRUG: Calcipotriene
DRUG: Tacrolimus

Sponsor

Medical College of Wisconsin

Collaborators

[object Object]
[object Object]
[object Object]